A detailed history of Bank Of Montreal transactions in Arvinas, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 38,363 shares of ARVN stock, worth $992,067. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,363
Holding current value
$992,067
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$23.66 - $32.73 $907,668 - $1.26 Million
38,363 New
38,363 $944,000
Q4 2022

Feb 01, 2023

BUY
$32.47 - $57.24 $4,675 - $8,242
144 New
144 $4,000
Q4 2021

Feb 11, 2022

SELL
$65.85 - $96.21 $2.27 Million - $3.32 Million
-34,457 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$73.2 - $107.87 $5,197 - $7,658
71 Added 0.21%
34,457 $2.96 Million
Q2 2021

Aug 12, 2021

BUY
$60.45 - $84.26 $2.08 Million - $2.9 Million
34,386 New
34,386 $2.63 Million

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.38B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.